Evidence map›Paper›PMID 38290664›Full record

ArticleThe Journal of infection2024

Burden of child mortality from malaria in high endemic areas: Results from the CHAMPS network using minimally invasive tissue sampling.

Ikechukwu U Ogbuanu, Kephas Otieno, Rosauro Varo, Samba O Sow, Julius Ojulong, Babatunde Duduyemi, Dickens Kowuor, Carrie Jo Cain, Emily A Rogena, Dickens Onyango and 30 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of infection, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
12.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Determinants of Knowledge of Malaria Prevention Among Women of Reproductive Age 15-49 Years in Nigeria.Nigerian medical journal : journal of the Nigeria Medical Association
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors at 17 institutions in 11 countries.

Ikechukwu U OgbuanuCrown Agents in Sierra Leone, Freetown, Sierra Leone.
Kephas OtienoKenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya.
Rosauro VaroISGlobal - Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça [CISM], Maputo, Mozambique.
Samba O SowCentre pour le Développement des Vaccins (CVD-Mali), Ministère de la Santé, Bamako, Mali.
Julius OjulongCrown Agents in Sierra Leone, Freetown, Sierra Leone.
Babatunde DuduyemiUniversity of Sierra Leone Teaching Hospital Complex, Freetown, Sierra Leone.
Dickens KowuorCrown Agents in Sierra Leone, Freetown, Sierra Leone.
Carrie Jo CainWorld Hope International, Makeni, Sierra Leone.
Emily A RogenaSchool of Medicine, Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya.
Dickens OnyangoKisumu County Department of Health, Kisumu, Kenya.
Victor AkeloUS Centers for Disease Control and Prevention--Kenya, Kisumu, Kenya.
Beth A Tippett BarrUS Centers for Disease Control and Prevention--Kenya, Kisumu, Kenya.
Feiko terKuileLiverpool School of Tropical Medicine, Liverpool, United Kingdom.
Karen L KotloffDepartment of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Milagritos D TapiaDepartment of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Adama Mamby KeitaCentre pour le Développement des Vaccins (CVD-Mali), Ministère de la Santé, Bamako, Mali.
Jane JumaCentre pour le Développement des Vaccins (CVD-Mali), Ministère de la Santé, Bamako, Mali.
Nega AssefaCollege of Health and Medical Sciences, Haramaya University, Harar, Ethiopia; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Nardos AssegidCollege of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Yenework AchamCollege of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Lola MadridCollege of Health and Medical Sciences, Haramaya University, Harar, Ethiopia; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.
J Anthony G ScottDepartment of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Shams El ArifeenInternational Center for Diarrhoeal Diseases Research (ICDDR,B), Dhaka, Bangladesh.
Emily S GurleyInternational Center for Diarrhoeal Diseases Research (ICDDR,B), Dhaka, Bangladesh; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Sana MahtabSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Ziyaad DangorSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Jeannette WadulaSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Jeanie DutoitSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Shabir A MadhiSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Wits Infectious Diseases and Oncology Research Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Inácio MandomandoISGlobal - Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça [CISM], Maputo, Mozambique; Instituto Nacional de Saúde, Ministério de Saúde, Maputo, Moçambique.
David Torres-FernandezISGlobal - Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça [CISM], Maputo, Mozambique.
Milton KincardettCentro de Investigação em Saúde de Manhiça [CISM], Maputo, Mozambique.
Rita MabundaCentro de Investigação em Saúde de Manhiça [CISM], Maputo, Mozambique.
Portia MutevedziEmory Global Health Institute, Emory University, Atlanta, GA, USA.
Zachary J MadewellGlobal Health Center, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Dianna M BlauGlobal Health Center, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Cynthia G WhitneyEmory Global Health Institute, Emory University, Atlanta, GA, USA.
Aaron M SamuelsGlobal Health Center, Centers for Disease Control and Prevention, Atlanta, GA, USA; Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Kisumu, Kenya.
Quique BassatISGlobal - Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça [CISM], Maputo, Mozambique; ICREA, Pg. Lluís Companys 23, 08010 Barcelona, Spain; Pediatrics Department, Hospital Sant Joan de Déu, Universitat de Barcelona, Esplugues, Barcelona, Spain; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: quique.bassat@isglobal.org.
CHAMPS consortium
Manhiça Health Research Centre · MZSouth African Medical Research Council · ZAHaramaya University · ETCenters for Disease Control and Prevention · USCentre Pour le Développement des Vaccins-Mali · MLSierra Leone Agricultural Research Institute · SLCenters for Disease Control and Prevention · KEEmory University · USKenya Medical Research Institute · KEUniversity of Maryland, Baltimore · USGreat Lakes University of Kisumu · KEInstitució Catalana de Recerca i Estudis Avançats · ESInternational Centre for Diarrhoeal Disease Research · BDJohns Hopkins University · USJomo Kenyatta University of Agriculture and Technology · KELiverpool School of Tropical Medicine · GBUniversity of Sierra Leone · SL

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundMalaria is a leading cause of childhood mortality worldwide. However, accurate estimates of malaria prevalence and causality among patients who die at the country level are lacking due to the limited specificity of diagnostic tools used to attribute etiologies. Accurate estimates are crucial for prioritizing interventions and resources aimed at reducing malaria-related mortality.

methodsSeven Child Health and Mortality Prevention Surveillance (CHAMPS) Network sites collected comprehensive data on stillbirths and children <5 years, using minimally invasive tissue sampling (MITS). A DeCoDe (Determination of Cause of Death) panel employed standardized protocols for assigning underlying, intermediate, and immediate causes of death, integrating sociodemographic, clinical, laboratory (including extensive microbiology, histopathology, and malaria testing), and verbal autopsy data. Analyses were conducted to ascertain the strength of evidence for cause of death (CoD), describe factors associated with malaria-related deaths, estimate malaria-specific mortality, and assess the proportion of preventable deaths.

findingsBetween December 3, 2016, and December 31, 2022, 2673 deaths underwent MITS and had a CoD attributed from four CHAMPS sites with at least 1 malaria-attributed death. No malaria-attributable deaths were documented among 891 stillbirths or 924 neonatal deaths, therefore this analysis concentrates on the remaining 858 deaths among children aged 1-59 months. Malaria was in the causal chain for 42.9% (126/294) of deaths from Sierra Leone, 31.4% (96/306) in Kenya, 18.2% (36/198) in Mozambique, 6.7% (4/60) in Mali, and 0.3% (1/292) in South Africa. Compared to non-malaria related deaths, malaria-related deaths skewed towards older infants and children (p < 0.001), with 71.0% among ages 12-59 months. Malaria was the sole infecting pathogen in 184 (70.2%) of malaria-attributed deaths, whereas bacterial and viral co-infections were identified in the causal pathway in 24·0% and 12.2% of cases, respectively. Malnutrition was found at a similar level in the causal pathway of both malaria (26.7%) and non-malaria (30.7%, p = 0.256) deaths. Less than two-thirds (164/262; 62.6%) of malaria deaths had received antimalarials prior to death. Nearly all (98·9%) malaria-related deaths were deemed preventable.

interpretationMalaria remains a significant cause of childhood mortality in the CHAMPS malaria-endemic sites. The high bacterial co-infection prevalence among malaria deaths underscores the potential benefits of antibiotics for severe malaria patients. Compared to non-malaria deaths, many of malaria-attributed deaths are preventable through accessible malaria control measures.

Indexed as

Child MortalityMalariaCause of DeathChildChild HealthFemaleHumansInfantInfant, NewbornPregnancyStillbirthChild mortalityCo-infectionsMalariaMITSPost-mortemPreventable deaths

Identifiers

PMID38290664
PMCPMC13019364
OpenAlexW4391289765

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.